NeuroXess raises 700 million yuan to fund brain implant trials and production
NeuroXess founder Tao Hu is pairing a multicenter registration trial with plans for a 14,300-square-meter factory targeting 10,000 units of capacity.
By RuntimeWire Staff · Published
Primary source: 新华财经 / 新浪财经
Why it matters
NeuroXess is funding clinical validation and manufacturing in parallel, tying its production plans to the outcome of its registration process.
NeuroXess, the Shanghai brain-computer interface startup founded by researcher Tao Hu, raised 700 million yuan in a Series B round to finance clinical trials, regulatory work and manufacturing for its implantable system, according to NeuroXess's announcement and Xinhu Finance's report on October 28th.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.